21
TITLE: Gastric adenocarcinoma development in patients with atrophy or/and intestinal metaplasia: the role of COX-2 polymorphisms in a Northern Portuguese population  Full Text
AUTHORS: Pereira, AC ; Sousa, H ; Pinto Correia, AL; Teixeira, AL; Fragoso, M; Moreira Dias, L; Rui Medeiros ; Dinis Ribeiro, M ;
PUBLISHED: 2010, SOURCE: 21st Meeting of the European-Association-for-Cancer-Research in EJC SUPPLEMENTS, VOLUME: 8, ISSUE: 5
INDEXED IN: WOS CrossRef
22
TITLE: Influence of TGFB1+869T > c polymorphism in non-small cell lung cancer (NSCLC) risk  Full Text
AUTHORS: Teixeira, AL; Araujo, A; Coelho, A; Gomes, M; Pereira, C; Ribeiro, R; Rui Medeiros ;
PUBLISHED: 2009, SOURCE: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology in EJC SUPPLEMENTS, VOLUME: 7, ISSUE: 2
INDEXED IN: WOS CrossRef: 1
23
TITLE: Influence of IL-4-590C/T polymorphism in Non-Small Cell Lung Cancer (NSCLC) susceptibility  Full Text
AUTHORS: Gomes, M; Coelho, A; Araujo, A; Catarino, R; Nogal, A; Teixeira, AL; Rui Medeiros ;
PUBLISHED: 2009, SOURCE: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology in EJC SUPPLEMENTS, VOLUME: 7, ISSUE: 2
INDEXED IN: WOS CrossRef
24
TITLE: 8473T > C COX-2 polymorphism and susceptibility for lung cancer: a strategy for individualised chemoprevention  Full Text
AUTHORS: Pereira, A; Machado, P; Araujo, A; Coelho, A; Teixeira, AL; Rui Medeiros ;
PUBLISHED: 2009, SOURCE: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology in EJC SUPPLEMENTS, VOLUME: 7, ISSUE: 2
INDEXED IN: WOS CrossRef
25
TITLE: VEGF genotypes as a prognostic factors in non-small cell lung cancer patients
AUTHORS: Ana P Coelho; Antonio Manuel Araujo; Monica Gomes; Ricardo Ribeiro; Ana L Teixeira; Raquel Catarino; Ana Nogal; Rui Medeiros ;
PUBLISHED: 2009, SOURCE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 4, ISSUE: 9
INDEXED IN: WOS
26
TITLE: Functional genetic polymorphisms in the leptin pathway are associated with progression free interval and overall survival in ovarian cancer patients  Full Text
AUTHORS: Ribeiro, R; Teixeira, AL; Pinto, D; Pereira, D ; Rui Medeiros ;
PUBLISHED: 2008, SOURCE: 20th Meeting of the European-Association-for-Cancer-Research in EJC SUPPLEMENTS, VOLUME: 6, ISSUE: 9
INDEXED IN: WOS CrossRef
27
TITLE: Genetic polymorphism in EGF is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients
AUTHORS: Ana L Teixeira; Ricardo Ribeiro ; Diana Cardoso; Daniela Pinto; Francisco Lobo; Avelino Fraga; Francisco Pina; Fernando Calais da Silva; Rui Medeiros ;
PUBLISHED: 2008, SOURCE: CLINICAL CANCER RESEARCH, VOLUME: 14, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 39
28
TITLE: HER2 polymorphism is associated with gastric cancer risk  Full Text
AUTHORS: Pinto, D; Faustino, C; Ferreira, P; Teixeira, AL; Pinto Correia, AL; Sousa, H ; Dinis Ribeiro, M ; Fragoso, M; Rui Medeiros ;
PUBLISHED: 2007, SOURCE: 14th European Cancer Conference (ECCO 14) in EJC SUPPLEMENTS, VOLUME: 5, ISSUE: 4
INDEXED IN: WOS CrossRef
29
TITLE: Epidermal growth factor (EGF)+61 A/G functional genetic polymorphism influences disease-free interval in androgen blockade treated prostate cancer patients  Full Text
AUTHORS: Teixeira, AL; Ribeiro, R; Cardoso, D; Pinto, D; Morais, A; Lobo, F; Calais da Silva, FM; Calais da Silva, FE; Rui Medeiros ;
PUBLISHED: 2007, SOURCE: 14th European Cancer Conference (ECCO 14) in EJC SUPPLEMENTS, VOLUME: 5, ISSUE: 4
INDEXED IN: WOS CrossRef
30
TITLE: Genetic polymorphism of the epidermal growth factor gene-value for the treatment of non-small cell lung cancer (NSCLC)  Full Text
AUTHORS: Araujo, A; Araujo, AP; Teixeira, AL; Coelho, A; Ribeiro, R; Azevedo, I; Catarino, R; Pinto, D; Soares, M; Rui Medeiros ;
PUBLISHED: 2007, SOURCE: 14th European Cancer Conference (ECCO 14) in EJC SUPPLEMENTS, VOLUME: 5, ISSUE: 4
INDEXED IN: WOS CrossRef
Página 3 de 3. Total de resultados: 30.